OTC: ARSUF - Fagron NV

Yield per half year: -3.93%
Dividend yield: 0.00%

Share chart Fagron NV


About Fagron NV

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding.

more details
Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.55
Дивиденд ао 0.2471
Сайт https://www.fagron.com
Цена ао 20.03
Change price per day: 0% (20.03)
Change price per week: 0% (20.03)
Change price per month: 0% (20.03)
Change price per 3 month: 0% (20.03)
Change price per half year: -3.93% (20.85)
Change price per year: +7.75% (18.589)
Change price per year to date: 0% (20.03)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.7143 7.14
Total: 3.94

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 56.52 7
Yield Ebitda, % 0 0
Yield EPS, % 22.08 4
Total: 5.4

Head Job title Payment Year of birth
Mr. Rafael Padilla CEO & Executive Director 1.2M 1978 (47 years)
Ms. Karin de Jong CFO & Executive Director 710.81k 1979 (46 years)
Ms. Vera Bakker Chief Operating Officer 8.03k 1972 (53 years)
Karen Berg Global Investor Relations Manager N/A
Mr. Johan Verlinden Head of Legal, Mergers & Acquisitions N/A

Address: Belgium, Nazareth, Venecoweg 20A - open in Google maps, open in Yandex maps
Website: https://www.fagron.com